NDC 63629-8265-01 - NP Thyroid 15
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-8265
- Requested NDC
- 63629-8265-01
- Package NDCs from labels
- 63629-8265-2, 63629-8265-3, 63629-8265-1, 63629-8265-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2025-04-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NP Thyroid 15 - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-8265-1 | NP Thyroid 15 | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 63629-8265-2 | NP Thyroid 15 | 90 in 1 BOTTLE | TABLET | 90 | 7 | |
| 63629-8265-3 | NP Thyroid 15 | 60 in 1 BOTTLE | TABLET | 60 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-8265 | NP THYROID 15 (LEVOTHYROXINE, LIOTHYRONINE) TABLET [BRYANT RANCH PREPACK] | 7 | Current NDC, Legacy NDC, 3 package rows | 20250424_647df9e7-5234-4de6-bce5-bb2cf0c5c7e6.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Ready to Use Mineral Oil Laxative | MINERAL OIL | Cardinal Health | b8494d02-8a7d-47b4-80b0-b8ab51b625fd | 2025-09-29 | Warnings | T5L8T28FGP |
| Dextrose | DEXTROSE MONOHYDRATE | ProPharma Distribution | 3eff8bcd-6a33-428f-e063-6394a90afa68 | 2025-09-17 | Warnings, Adverse reactions | LX22YL083G |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | LX22YL083G |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | Baxter Healthcare Company | dcbf1907-1841-4afc-ab5d-a9893a2d7256 | 2025-08-26 | Warnings, Adverse reactions | LX22YL083G |
| Exchange Select Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Army & Air Force Exchange Service | 6c32af3e-5b60-4e3e-95c2-ada37a7d3b2a | 2025-08-22 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Padagis Israel Pharmaceuticals Ltd | 43826c68-0a20-460d-a7b5-f3e12395a7d0 | 2025-08-22 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Publix Super Markets Inc | 7b360d3b-fb2b-4f35-a04d-203dd352933d | 2025-08-19 | Warnings | T5L8T28FGP |
| Good Sense Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | L. Perrigo Company | 2492ee1b-01f1-46e7-8790-b6ebc48f2aff | 2025-08-19 | Warnings | T5L8T28FGP |
| NP Thyroid | THYROID TABLETS | Calvin Scott & Co Inc. | 3c25a33b-4433-eb91-e063-6394a90a6ffe | 2025-08-12 | Warnings | 1855086 314267 06LU7C9H1V Q51BO43MG4 |
| NP Thyroid | THYROID TABLETS | Calvin Scott & Co Inc. | 3c2688e4-e703-4213-e063-6394a90a7057 | 2025-08-12 | Warnings | 1855086 314267 06LU7C9H1V Q51BO43MG4 |
| NP Thyroid | THYROID TABLETS | Calvin Scott & Co Inc. | 3c270b9a-05c2-6a30-e063-6394a90a2844 | 2025-08-12 | Warnings | 1855086 314267 06LU7C9H1V Q51BO43MG4 |
| DG Health Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Dolgencorp, LLC | d9f12a34-7bd1-4ba5-b34b-1b641f58271a | 2025-08-12 | Warnings | T5L8T28FGP |
| Stye | MINERAL OIL AND PETROLATUM | Insight Pharmaceuticals LLC | f7eb8466-d8ea-4833-9bed-244ead38a3bf | 2025-08-11 | Warnings | T5L8T28FGP |
| NP Thyroid | THYROID TABLETS | Calvin Scott & Co Inc. | 3bfbcbe6-8b71-1854-e063-6394a90a589d | 2025-08-10 | Warnings | 1724439 313387 06LU7C9H1V Q51BO43MG4 |
| NP Thyroid | THYROID TABLETS | Calvin Scott & Co Inc. | 3bfc5cfe-b654-2faf-e063-6294a90ade3c | 2025-08-10 | Warnings | 1724439 313387 06LU7C9H1V Q51BO43MG4 |
| NP Thyroid | THYROID TABLETS | Calvin Scott & Co Inc. | 3bfcc004-1264-9215-e063-6294a90aeac2 | 2025-08-10 | Warnings | 1724439 313387 06LU7C9H1V Q51BO43MG4 |
| NP Thyroid | THYROID TABLETS | Calvin Scott & Co Inc. | 3bfe2735-51bb-48a2-e063-6394a90a114e | 2025-08-10 | Warnings | 313391 1724481 06LU7C9H1V Q51BO43MG4 |
| NP Thyroid | THYROID TABLETS | Calvin Scott & Co Inc. | 3bfea332-5d8c-a4e9-e063-6294a90a727f | 2025-08-10 | Warnings | 313391 1724481 06LU7C9H1V Q51BO43MG4 |
| NP Thyroid | THYROID TABLETS | Calvin Scott & Co Inc. | 3bff08d3-9878-b516-e063-6394a90a65e3 | 2025-08-10 | Warnings | 313391 1724481 06LU7C9H1V Q51BO43MG4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.